Our data point to a novel aspect in the molecular pathogenesis of RASopathies as we uncovered RIT1 as regulator of cytoskeletal changes through the RHO GTPases RAC1 and CDC42 and their effector PAK1. The gene discussed is CDC42; the disease is RASopathy.